Proposed Data Collection Submitted for Public Comment and Recommendations, 9346-9348 [2021-02952]
Download as PDF
<![CDATA[
9346
Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices
Background and Brief Description
The National Center for Health
Statistics (NCHS) has submitted a sixmonth OMB emergency clearance for a
Research and Development Survey
(RANDS) COVID–19 related data
collection. Since COVID–19 has resulted
in a public health crisis, this
information collection requests approval
to conduct a follow-on survey (Round 3)
to the previously completed rounds of
RANDS. Similar to the previous two
rounds of RANDS completed during
COVID–19, this information collection
RANDS will provide NCHS and CDC
with early estimates of COVID–19related concepts. The questionnaire will
cover areas such as general health,
psychological distress, chronic
conditions, health behaviors, the
outbreak’s effects on healthcare access,
loss of work due to illness with COVID–
19, telemedicine access and use, and
other health and behavioral aspects
related to the epidemic. CDC requests
approval for an estimated 1,734 burden
hours over the course of the six-month
approval. There are no costs to
respondents other than their time.
will use NORC’s AmeriSpeak Panel as
its sample source.
The RANDS COVID–19 (Round 3)
collection will be used for the purpose
of continuing NCHS’ developmental
survey methods and will generate data
that can help explain health-related
experiences of the United States
population during this period. The data
collection includes not only a research
component, but will also contribute to
CDC’s ongoing surveillance of the
COVID–19 pandemic. Given the current
outbreak and the resulting limitations
placed on NCHS’ other data collections,
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
participants
Number of
responses/
participant
Average hours
per response
Response
burden
(in hours)
Types of respondents
Form name
Individuals or households .................
RANDS–COVID–19 Round 3 ..........
5,200
1
20/60
1,734
Total ...........................................
...........................................................
5,200
........................
........................
1,734
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–02950 Filed 2–11–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0840 Docket No. CDC–2021–
0010]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘NCHHSTP Generic Clearance
Formative Research and Tool
Development’’. This information
collection request is designed to allow
CDC’s National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
SUMMARY:
VerDate Sep<11>2014
17:27 Feb 11, 2021
Jkt 253001
(NCHHSTP) to conduct formative
research information collection
activities used to inform many aspects
of surveillance, communications, health
promotion, and research project
development for NCHHSTP’s four
priority diseases (HIV/AIDS), sexually
transmitted diseases/infections (STD/
STI), viral hepatitis, tuberculosis
elimination (TB), and school and
adolescent health (DASH).
DATES: CDC must receive written
comments on or before April 13, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0010 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
E:\FR\FM\12FEN1.SGM
12FEN1
9347
Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
NCHHSTP Generic Clearance
Formative Research and Tool
Development (OMB Control No. 0920–
0840, Exp. 10/31/2021)—Extension—
National Center for HIV/AIDS, Viral
Hepatitis, STD, TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention, National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP) requests
approval for an extension and a three
year approval for the previously
approved Generic Clearance,
‘‘Formative Research and Tool
Development’’. This information
collection request is designed to allow
NCHHSTP to conduct formative
research information collection
activities used to inform many aspects
of surveillance, communications, health
promotion, and research project
development for NCHHSTP’s four
priority diseases (HIV/AIDS, sexually
transmitted diseases/infections (STD/
STI), viral hepatitis, tuberculosis
elimination and the Division of School
and Adolescent Heath (DASH).
Formative research is the basis for
developing effective strategies including
communication channels, for
influencing behavior change. It helps
researchers identify and understand the
characteristics—interests, behaviors and
needs—of target populations that
influence their decisions and actions.
Formative research is integral in
developing programs as well as
improving existing and ongoing
programs. Formative research also looks
at the community in which a public
health intervention is being or will be
implemented and helps the project staff
understand the interests, attributes and
answer questions and ways in which
question response bias and error can be
reduced.
This request also includes collection
of information from public health
programs to assess needs related to
initiation of a new program activity or
expansion or changes in scope or
implementation of existing program
activities to adapt them to current
needs. The information collected will be
used to advise programs and provide
capacity-building assistance tailored to
identified needs. Overall, these
development activities are intended to
provide information that will increase
the success of the surveillance or
research projects through increasing
response rates and decreasing response
error, thereby decreasing future data
collection burden to the public. The
studies that will be covered under this
request will include one or more of the
following investigational modalities: (1)
Structured and qualitative interviewing
for surveillance, research, interventions
and material development, (2) cognitive
interviewing for development of specific
data collection instruments, (3)
methodological research (4) usability
testing of technology-based instruments
and materials, (5) field testing of new
methodologies and materials, (6)
investigation of mental models for
health decision-making, to inform
health communication messages, and (7)
organizational needs assessments to
support development of capacity.
Respondents who will participate in
individual and group interviews
(qualitative, cognitive, and computer
assisted development activities) are
selected purposively from those who
respond to recruitment advertisements.
In addition to utilizing advertisements
for recruitment, respondents who will
participate in research on survey
methods may be selected purposively or
systematically from within an ongoing
surveillance or research project.
Participation by respondents is
voluntary. There is no cost to
participants other than their time.
needs of different populations and
persons in that community. Formative
research is research that occurs before a
program is designed and implemented,
or while a program is being conducted.
NCHHSTP formative research is
necessary for developing new programs
or adapting programs that deal with the
complexity of behaviors, social context,
cultural identities, and health care that
underlie the epidemiology of HIV/AIDS,
viral hepatitis, STDs, and TB in the
U.S., as well as for school and
adolescent health.
CDC conducts formative research to
develop public-sensitive
communication messages and user
friendly tools prior to developing or
recommending interventions, or care.
Sometimes these studies are entirely
behavioral but most often they are
cycles of interviews and focus groups
designed to inform the development of
a product. Products from these
formative research studies will be used
for prevention of HIV/AIDS, Sexually
Transmitted Infections (STI), viral
Hepatitis, and Tuberculosis. Findings
from these studies may also be
presented as evidence to diseasespecific National Advisory Committees,
to support revisions to recommended
prevention and intervention methods, as
well as new recommendations.
Much of CDC’s health communication
takes place within campaigns that have
lengthy planning periods—timeframes
that accommodate the standard Federal
process for approving data collections.
Short term qualitative interviewing and
cognitive research techniques have
previously proven invaluable in the
development of scientifically valid and
population-appropriate methods,
interventions, and instruments.
This request includes studies
investigating the utility and
acceptability of proposed sampling and
recruitment methods, intervention
contents and delivery, questionnaire
domains, individual questions, and
interactions with project staff or
electronic data collection equipment.
These activities will also provide
information about how respondents
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
General public
viders.
General public
viders.
General public
viders.
General public
viders.
VerDate Sep<11>2014
Number of
respondents
Form name
Number of
responses per
respondent
Average hours
per response
Total response
burden
(hours)
and health care pro-
Screener ...........................................
81,200
1
10/60
13,533
and health care pro-
Consent Forms .................................
40,600
1
5/60
3,383
and health care pro-
Individual Interview ...........................
6,600
1
1
6,600
and health care pro-
Focus Group Interview .....................
4,000
1
2
8,000
17:27 Feb 11, 2021
Jkt 253001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
E:\FR\FM\12FEN1.SGM
12FEN1
9348
Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
General public and health care providers.
Survey of Individual ..........................
Total ...........................................
...........................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–02952 Filed 2–11–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers CMS–10518 and
CMS–10340]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
April 13, 2021.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
SUMMARY:
VerDate Sep<11>2014
17:27 Feb 11, 2021
Jkt 253001
Number of
responses per
respondent
Average hours
per response
Total response
burden
(hours)
30,000
1
30/60
15,000
........................
........................
........................
46,516
Number of
respondents
Type of respondent
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number llll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
https://www.cms.gov/Regulations-andGuidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10518 Application for
Participation in the Intravenous
Immune Globulin (IVIG)
Demonstration
CMS–10340 Collection of Encounter
Data from MA Organizations
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Application for
Participation in the Intravenous
Immune Globulin (IVIG) Demonstration;
Use: Traditional fee-for-service (FFS)
Medicare covers some or all
components of home infusion services
depending on the circumstances. By
special statutory provision, Medicare
Part B covers intravenous immune
globulin (IVIG) for persons with primary
immune deficiency disease (PIDD) who
wish to receive the drug at home.
However, Medicare does not separately
pay for any services or supplies to
administer it if the person is not
homebound and otherwise receiving
services under a Medicare Home Health
episode of care. As a result, many
beneficiaries have chosen to receive the
drug at their doctor’s office or in an
outpatient hospital setting.
The Medicare IVIG Demonstration
application requests basic demographic
information necessary to determine
eligibility for participation in the
demonstration. This information is used
by CMS’ implementation support
contractor to determine eligibility for
the demonstration and to set up a
demonstration eligibility record that is
used by the Medicare claims system
when processing claims for
demonstration services.
The application also includes some
questions about how and where the
beneficiary is currently receiving
immunoglobulin and related services.
This data is being used by the
evaluation contractor to conduct its
evaluation and to better understand
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 86, Number 28 (Friday, February 12, 2021)]
[Notices]
[Pages 9346-9348]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02952]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0840 Docket No. CDC-2021-0010]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``NCHHSTP Generic Clearance
Formative Research and Tool Development''. This information collection
request is designed to allow CDC's National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention (NCHHSTP) to conduct formative
research information collection activities used to inform many aspects
of surveillance, communications, health promotion, and research project
development for NCHHSTP's four priority diseases (HIV/AIDS), sexually
transmitted diseases/infections (STD/STI), viral hepatitis,
tuberculosis elimination (TB), and school and adolescent health (DASH).
DATES: CDC must receive written comments on or before April 13, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0010 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
[[Page 9347]]
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
NCHHSTP Generic Clearance Formative Research and Tool Development
(OMB Control No. 0920-0840, Exp. 10/31/2021)--Extension--National
Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention (NCHHSTP),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention, National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) requests
approval for an extension and a three year approval for the previously
approved Generic Clearance, ``Formative Research and Tool
Development''. This information collection request is designed to allow
NCHHSTP to conduct formative research information collection activities
used to inform many aspects of surveillance, communications, health
promotion, and research project development for NCHHSTP's four priority
diseases (HIV/AIDS, sexually transmitted diseases/infections (STD/STI),
viral hepatitis, tuberculosis elimination and the Division of School
and Adolescent Heath (DASH). Formative research is the basis for
developing effective strategies including communication channels, for
influencing behavior change. It helps researchers identify and
understand the characteristics--interests, behaviors and needs--of
target populations that influence their decisions and actions.
Formative research is integral in developing programs as well as
improving existing and ongoing programs. Formative research also looks
at the community in which a public health intervention is being or will
be implemented and helps the project staff understand the interests,
attributes and needs of different populations and persons in that
community. Formative research is research that occurs before a program
is designed and implemented, or while a program is being conducted.
NCHHSTP formative research is necessary for developing new programs or
adapting programs that deal with the complexity of behaviors, social
context, cultural identities, and health care that underlie the
epidemiology of HIV/AIDS, viral hepatitis, STDs, and TB in the U.S., as
well as for school and adolescent health.
CDC conducts formative research to develop public-sensitive
communication messages and user friendly tools prior to developing or
recommending interventions, or care. Sometimes these studies are
entirely behavioral but most often they are cycles of interviews and
focus groups designed to inform the development of a product. Products
from these formative research studies will be used for prevention of
HIV/AIDS, Sexually Transmitted Infections (STI), viral Hepatitis, and
Tuberculosis. Findings from these studies may also be presented as
evidence to disease-specific National Advisory Committees, to support
revisions to recommended prevention and intervention methods, as well
as new recommendations.
Much of CDC's health communication takes place within campaigns
that have lengthy planning periods--timeframes that accommodate the
standard Federal process for approving data collections. Short term
qualitative interviewing and cognitive research techniques have
previously proven invaluable in the development of scientifically valid
and population-appropriate methods, interventions, and instruments.
This request includes studies investigating the utility and
acceptability of proposed sampling and recruitment methods,
intervention contents and delivery, questionnaire domains, individual
questions, and interactions with project staff or electronic data
collection equipment. These activities will also provide information
about how respondents answer questions and ways in which question
response bias and error can be reduced.
This request also includes collection of information from public
health programs to assess needs related to initiation of a new program
activity or expansion or changes in scope or implementation of existing
program activities to adapt them to current needs. The information
collected will be used to advise programs and provide capacity-building
assistance tailored to identified needs. Overall, these development
activities are intended to provide information that will increase the
success of the surveillance or research projects through increasing
response rates and decreasing response error, thereby decreasing future
data collection burden to the public. The studies that will be covered
under this request will include one or more of the following
investigational modalities: (1) Structured and qualitative interviewing
for surveillance, research, interventions and material development, (2)
cognitive interviewing for development of specific data collection
instruments, (3) methodological research (4) usability testing of
technology-based instruments and materials, (5) field testing of new
methodologies and materials, (6) investigation of mental models for
health decision-making, to inform health communication messages, and
(7) organizational needs assessments to support development of
capacity.
Respondents who will participate in individual and group interviews
(qualitative, cognitive, and computer assisted development activities)
are selected purposively from those who respond to recruitment
advertisements. In addition to utilizing advertisements for
recruitment, respondents who will participate in research on survey
methods may be selected purposively or systematically from within an
ongoing surveillance or research project. Participation by respondents
is voluntary. There is no cost to participants other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Form name Number of responses per Average hours Total response
respondents respondent per response burden (hours)
----------------------------------------------------------------------------------------------------------------
General public and health care Screener........ 81,200 1 10/60 13,533
providers.
General public and health care Consent Forms... 40,600 1 5/60 3,383
providers.
General public and health care Individual 6,600 1 1 6,600
providers. Interview.
General public and health care Focus Group 4,000 1 2 8,000
providers. Interview.
[[Page 9348]]
General public and health care Survey of 30,000 1 30/60 15,000
providers. Individual.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 46,516
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-02952 Filed 2-11-21; 8:45 am]
BILLING CODE 4163-18-P
